Hidalgo Pardo F, Gutiérrez Sanz-Gadea C, Rebassa Llull M J, García Bueno J M, Mus Malleu A, Losada González G P, Ozonas Moragues M
Servicio de Urología, Hospital Son Dureta, Palma de Mallorca.
Actas Urol Esp. 1998 Jan;22(1):29-33.
Immunotherapy management for advanced renal carcinoma has awaken a growing interest over the last few years. Based on Atzpodien's studies, in December 1994 a protocol was initiated in our centre for the treatment of metastatic renal carcinoma, using subcutaneous alpha interferon, subcutaneous Interleukin-2 and endovenous 5-Fluorouracil. The present report analyzes all six cases included in the protocol and their results.
